Skip Navigation LinksHome > October 2012 - Volume 60 - Issue 7 > Polymorphism G80A in the Reduced Folate Carrier Gene and its...
Journal of Investigative Medicine:
doi: 10.231/JIM.0b013e31826803c1
Brief Reports

Polymorphism G80A in the Reduced Folate Carrier Gene and its Relationship to Survival and Risk of Relapse in Acute Lymphoblastic Leukemia

Leyva-Vázquez, Marco Antonio PhD*; Organista-Nava, Jorge MSc; Gómez-Gómez, Yazmín MSc; Contreras-Quiroz, Adriana MSc*; Flores-Alfaro, Eugenia PhD; Illades-Aguiar, Berenice PhD*

Collapse Box

Abstract

Background: The reduced folate carrier (RFC1) is a major methotrexate transporter whose impaired function was recognized as a frequent mechanism of antifolate resistance. Recently, a G80A polymorphism has been described in the RFC1. This study evaluated the effect of the G80A polymorphism in the RFC1 gene on survival and risk of relapse of acute lymphoblastic leukemia.

Methods and Results: Seventy patients with acute lymphoblastic leukemia were genotyped by polymerase chain reaction restriction fragment length polymorphism method. An association between the polymorphism and risk of relapse was found (P < 0.05). Patients with the G/A genotype have 3.97 (95% confidence interval, 1.12–14.06) and carriers of the A/A genotype have 7.84 (95% confidence interval, 1.66–37.10) higher chance of a relapse. Other variables such as age and leukocyte count were associated (P < 0.05) with the risk of relapse of disease. Individuals with G/A or A/A genotypes had poorer survival (log-rank test, P = < 0.05).

Conclusions: These data suggest a role of the polymorphism G80A in the risk of relapse and the mortality risk in patients with acute lymphoblastic leukemia from the State of Guerrero, Mexico.

Copyright © 2012 by the American Federation for Medical Research.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.